MCM
UTHR icon

Maryland Capital Management’s United Therapeutics UTHR Stock Holding History

Maryland Capital Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-160,044
Closed -$17M – 164
2016
Q2 		$17M Sell
160,044
-26,413
-14% -$2.95M 2.67% 14
2016
Q1 		$20.8M Buy
186,457
+14,973
+9% +$1.89M 2.99% 9
2015
Q4 		$26.9M Buy
171,484
+24,904
+17% +$3.63M 3.96% 3
2015
Q3 		$19.2M Buy
146,580
+697
+0.5% +$112K 3.25% 8
2015
Q2 		$25.4M Buy
145,883
+805
+0.6% +$145K 3.95% 3
2015
Q1 		$25M Buy
145,078
+805
+0.6% +$123K 3.9% 3
2014
Q4 		$18.7M Buy
144,273
+1,532
+1% +$197K 3.07% 7
2014
Q3 		$18.4M Buy
142,741
+380
+0.3% +$39.2K 3.17% 5
2014
Q2 		$12.6M Buy
142,361
+5,462
+4% +$525K 2.21% 21
2014
Q1 		$12.9M Sell
136,899
-8,440
-6% -$863K 2.36% 19
2013
Q4 		$16.4M Buy
145,339
+106
+0.1% +$9.56K 2.61% 8
2013
Q3 		$11.5M Buy
145,233
+33,253
+30% +$2.43M 1.86% 24
2013
Q2 		$7.37M Buy
+111,980
New +$7.21M 1.28% 25

Other funds holding UTHR

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Maryland Capital Management's UTHR Position: Q3 2016 in Review

Maryland Capital Management sold out of United Therapeutics (UTHR) in Q3 2016, closing a stake of 160,044 shares — an estimated $17M sold.

Maryland Capital Management first reported a position in UTHR in Q2 2013 and held it in 13 quarters. The position peaked at $26.9M in Q4 2015. 394 funds tracked by Wall St. Rank hold UTHR as of Q3 2016.

  • Maryland Capital Management reported no remaining United Therapeutics position as of Q3 2016 after selling out during the quarter.
  • Maryland Capital Management sold 160,044 United Therapeutics shares in Q3 2016, an estimated $17M.
  • Maryland Capital Management first reported a position in United Therapeutics in Q2 2013 and held it in 13 quarters.
  • Maryland Capital Management's United Therapeutics position peaked at $26.9M in Q4 2015.
  • 394 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2016.

Based on Maryland Capital Management's 13F filing for Q3 2016, filed 15 Nov 2016.